home / stock / nvs / nvs articles

NVS Articles, Novartis AG - From 04/09/24

Stock Information
Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Website: novartis.com
Menu
NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...
Novartis To Axe 680 Development Jobs Amid Global Reshuffle: Report | Benzinga

Novartis AG (NYSE:NVS) reportedly plans to slash up to 680 positions in its development organization, aiding in drug market launches. The...
Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population | Benzinga

Friday, the FDA approved Johnson & Johnson (NYSE:JNJ) Carvykti (ciltacabtagene autoleucel; cilta-cel) for relapsed or refractory mult...

Why Is Novartis Stock Trading Higher On Thursday? | Benzinga

Thursday, Novartis AG (NYSE:NVS) shares are trading higher after the company confirmed plans to file for Pluvicto pre-taxane la...

Magnificent 7 Stocks Become The Star Attractions For Norway's Sovereign Wealth Fund | Benzinga

If anyone needs any proof of how the landscape of investment has changed as a result of a handful of technology companies over the past decade, tak...
Ozempic Users Speak Out Over Side Effects, Lawsuits Against Novo Nordisk And Eli Lilly Surge | Benzinga

Scores of patients are reportedly taking legal action against pharmaceutical giants Eli Lilly And Co (NYSE:LLY) and Novo Nordisk A/S...

GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy | Benzinga

Key Takeaways: GenScript’s cell therapy revenue grew by 143.7% last year as a CAR-T cell therapy developed by its Legend Biotech subsidiary ...

Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform | Benzinga

H.C. Wainwright initiated coverage on Voyager Therapeutics Inc (NASDAQ:VYGR), noting a growing franchise of novel, highly-differenti...
FDA Approves BeiGene's First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer | Benzinga

On Thursday, the FDA approved BeiGene Ltd’s (NASDAQ:BGNE) approved Tevimbra (tislelizumab-jsgr) as monotherapy for adult patients w...

Medicare's Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029 | Benzinga

In a move outlined in his upcoming State of the Union address, President Joe Biden is pushing for an increase in the number of prescripti...

Biogen's Spinraza For Muscle Movement Disorder Shows Improved Motor Function In Infants, Toddlers | Benzinga

Biogen Inc (NASDAQ:BIIB) released interim 6-month biomarker data from the initial 29 participants in the open-label RESPOND study. The Ph...
Previous 10 Next 10